TheProfitWatch

ALMS - Alumis Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.9 0.54 (7.87%) -0.01 (-0.1%) 0.0 (0.04%) -0.27 (-3.47%) -0.1 (-1.45%) 0.59 (8.65%) 0.1 (1.47%) 0.01 (0.15%)

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.82
Diluted EPS:
-1.82
Basic P/E:
-4.0895
Diluted P/E:
-4.0895
RSI(14) 1m:
37.39
VWAP:
7.45
RVol:

Events

Period Kind Movement Occurred At

Related News